Skip to main content
All lobbying filings

THE WASHINGTON TAX & PUBLIC POLICY GROUP

Lobbying for MODERNATX, INC. · Pharmaceutical and biotechnology company.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · $30,000.00 income · posted Jan 16, 2026

Official filing document

 Bills named in this filing 5
  • HR 1990
    American Innovation and R&D Competitiveness Act of 2025
  • S 1639
    American Innovation and Jobs Act
  • HR 1062
    Growing and Preserving Innovation in America Act of 2025
  • HR 1414
    Cameron’s Law
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 1
Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 45C, 951A, 250, and 174. (H.R. 1990, S. 1639, H.R. 1062, H.R. 1414, H.R. 1 - Sections 70231, 70322, 70323, 70302).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem